To evaluate mitochondrial functionality in fibroblasts of ALS/FTD patients carrying pathogenic mutations in TARDBP and C9ORF72 genes, we first analyzed mitochondria morphology and network organization as potential indicators of their pathophysiology. This evidence concerns the gene C9orf72 and frontotemporal dementia.